Anti-cachectic effect of FK317, a novel anti-cancer agent, in Colon26 and LX-1 models in mice

Japanese Journal of Cancer Research

Volumn 89, Issue 12, 1998, Pages 1318-1325

  Naoe, Yoshinori ^a   Kawamura, Ikuo ^a   Inami, Masamichi ^a   Matsumoto, Sanae ^a   Nishigaki, Fusako ^a   Tsujimoto, Susumu ^a   Manda, Toshitaka ^a   Shimomura, Kyoichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Cachexia; Colon26; FK317; LX 1; Weight loss

Indexed keywords

1 ACETYL 8 CARBAMOYLOXYMETHYL 3,9 EPOXY 5 FORMYL 1A,2,3,8,9,9A HEXAHYDRO 9 HYDROXY 7 METHOXY 1H AZIRINO[2,3 C][1]BENZAZOCINE ACETATE; 1 ACETYL 8ALPHA (CARBAMOYLOXYMETHYL) 3,9 EPOXY 5 FORMYL 1,1A,2,8,9,9A OCTAHYDROAZIRINO[2,3 C][1]BENZAZOCINE 7,9 DIOL ACETATE; BENZOXAZINE DERIVATIVE; GLUCOSE; MITOMYCIN C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CACHEXIA; CARCASS; COLON CARCINOMA; EPIDIDYMIS FAT; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; WEIGHT REDUCTION;

EID: 0032457256     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00529.x     Document Type: Article

References (21)

1. Shimomura, K., Manda, T., Mukumoto, S., Masuda, K., Nakamura, T., Mizota, T., Matsumoto, S., Nishigaki, F., Oku, T., Mori, J. and Shibayama, F. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice. Cancer Res., 48, 1166-1172 (1988).
2. Iwami, M., Kiyoto, S., Terano, H., Kohsaka, M., Aoki, H. and Imanaka, H. A new antitumor antibiotic, FR-900482 (I). Taxonomic studies on the producing strain: a new species of genus Streptomyces. J. Antibiot. (Tokyo), 40, 589-593 (1987).
3. Kiyoto, S., Shibata, T., Yamashita, M., Komori, T., Okuhara, M., Terano, H., Kohsaka, M. and Aoki, H. A new antitumor antibiotic, FR-900482 (II). Production, isolation, characterization and biological activity. J. Antibiot. (Tokyo), 40, 594-599 (1987).
4. Shimomura, K., Hirai, O., Mizota, T., Matsumoto, S., Mori, J., Shibayama, F. and Kikuchi, H. A new antitumor antibiotic, FR-900482 (III). Antitumor activity in transplantable experimental tumors. J. Antibiot. (Tokyo), 40, 600-606 (1987).
5. Majima, H., Hasegawa, K., Fukuoka, M., Furuse, K., Wakui, A., Furue, H., Masaoka, T., Hattori, T., Taguchi, T., Ogura, T. and Niitani, H. Phase I clinical and pharmacokinetic study of FK973. Proc. Am. Soc. Clin. Oncol., 9, 78 (1990).
6. Pazdur, R., Ho, D. H., Daugherty, K., Bradner, W. T., Krakoff, I. H. and Raber, M. N. Phase I trial of FK973: description of a delayed vascular leak syndrome. Invest. New Drugs, 9, 377-382 (1991).
7. Naoe, Y., Inami, M., Matsumoto, S., Nishigaki, F., Tsujimoto, S., Kawamura, I., Miyayasu, K., Manda, T. and Shimomura, K. FK317; a novel substituted dihydrobenzoxazine with potent antitumor activity and without inducing vascular leak syndrome. Cancer Chemother. Pharmacol., 42, 31-36 (1998).
8. DeWys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., Horton, J., Johnson, G. J., Moertel, C. G., Oken, M. M., Perlia, C., Rosenbaum, C., Silverstein, M. N., Skeel, R. T., Sponzo, R. W. and Tormey, D. C. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med., 69, 491-497 (1980).
9. Lazo, P. A. Tumor-host metabolic interaction and cachexia. FEBS Lett., 187, 189-192 (1985).
10. Curtis, E. B., Krech, R. and Walsh, T. D. Common symptoms in patients with advanced cancer. J. Palliat. Care, 7, 25-29 (1991).
11. Kern, K. A. and Norton, J. A. Cancer cachexia. J. Parenter. Enteral. Nutr., 12, 286-298 (1988).
12. Corbett, T. H., Griswold, D. P., Jr., Robert, B. J., Peckham, J. C. and Schabel, F. M., Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res., 35, 2434-2439 (1975).
13. Tanaka, Y., Eda, H., Tanaka, T., Udagawa, T., Ishikawa, T., Horii, I., Ishitsuka, H., Kataoka, T. and Taguchi, T. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res., 50, 2290-2295 (1990).
14. Goldin, A., Venditti, J. M., Macdonald, J. S., Muggia, F. M., Henney, J. E. and Devita, V. T., Jr. Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. Eur. J. Cancer, 17, 129-142 (1981).
15. Tashiro, T., Inaba, M., Kobayashi, T., Sakurai, Y., Maruo, K., Ohnishi, Y., Ueyama, Y. and Nomura, T. Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses. Cancer Chemother. Pharmacol., 24, 187-192 (1989).
16. Strassmann, G., Fong, M., Kenney, J. S. and Jacob, C. O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest., 89, 1681-1684 (1992).
17. Strassmann, G., Jacob, C. O., Evans, R., Beall, D. and Fong, M. Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J. Immunol., 148, 3674-3678 (1992).
18. Strassmann, G., Masui, Y., Chizzonite, R. and Fong, M. Mechanisms of experimental cancer cachexia: local involvement of IL-1 in colon-26 tumor. J. Immunol., 150, 2341-2345 (1993).
19. Yamamoto, N., Kawamura, I., Nishigaki, F., Tsujimoto, S., Naoe, Y., Inami, M., Lacey, E., Manda, T. and Shimomura, K. Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26-induced cachexia in mice. Anticancer Res., 18, 139-144 (1998).
20. Kawamura, I., Morishita, R., Tomita, N., Lacey, E., Aketa, M., Tsujimoto, S., Manda, T., Tomoi, M., Kida, I., Higaki, J., Kaneda, Y., Shimomura, K. and Ogihara, T. Injection of oligonucleotides to NFκB binding site specifically inhibited cachexia in a mouse tumor model. Gene Ther., 5 (1998), in press.
21. Naoe, Y., Inami, M., Matsumoto, S., Takagaki, S., Fujiwara, T., Yamazaki, S., Kawamura, I., Nishigaki, F., Tsujimoto, S., Manda T. and Shimomura, K. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice. Jpn. J. Cancer Res., 89, 1306-1317 (1998).